Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions.
about
Role of Peroxisome Proliferator-Activated Receptors in Inflammation ControlA semi-quantitative RT-PCR method to measure thein vivo effect of dietary conjugated linoleic acid on porcine muscle PPAR gene expressionPPAR-gamma: a thrifty transcription factorArachidonic acid as a bioactive moleculeModulation of membrane lipid composition and homeostasis in salmon hepatocytes exposed to hypoxia and perfluorooctane sulfonamide, given singly or in combinationMonitoring Solution Structures of Peroxisome Proliferator-Activated Receptor β/δ upon Ligand BindingKeratinocyte growth factor and the transcription factors C/EBP alpha, C/EBP delta, and SREBP-1c regulate fatty acid synthesis in alveolar type II cellsThe dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis.Studies on induction of lamotrigine metabolism in transgenic UGT1 mice.Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role?PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues.Peroxisome proliferator-activated receptors in atherosclerosis and inflammation--an update.Fatty acid oxidation and signaling in apoptosis.Vascular effects of GI262570X (PPAR-gamma agonist) in the brown adipose tissue of Han Wistar rats: a review of 1-month, 13-week, 27-week and 2-year oral toxicity studies.Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infectionPPARγ ligands decrease hydrostatic pressure-induced platelet aggregation and proinflammatory activityPeroxisome proliferator-activated receptors and cancer: challenges and opportunitiesMetabolic Functions of Peroxisome Proliferator-Activated Receptor beta/delta in Skeletal Muscle.Significance of anti-inflammatory effects of PPARgamma agonists?Fatty acid receptors as new therapeutic targets for diabetes.Peroxisome proliferator-activated receptors: "key" regulators of neuroinflammation after traumatic brain injury.PPAR Ligands for Cancer Chemoprevention.Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's DiseaseRole of peroxisome proliferator-activated receptor alpha in the control of cyclooxygenase 2 and vascular endothelial growth factor: involvement in tumor growth.Peroxisome Proliferator-Activated Receptor Delta: A Conserved Director of Lipid Homeostasis through Regulation of the Oxidative Capacity of Muscle.Blocking the peroxisome proliferator-activated receptor (PPAR): an overview.Effect of oxime ether incorporation in acyl indole derivatives on PPAR subtype selectivity.Rosiglitazone ameliorates cisplatin-induced renal injury in mice.Lipid peroxidation and oxidative stress responses in juvenile salmon exposed to waterborne levels of the organophosphate compounds tris(2-butoxyethyl)- and tris(2-chloroethyl) phosphates.ERK5 activation inhibits inflammatory responses via peroxisome proliferator-activated receptor delta (PPARdelta) stimulation.Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells.Antagonism of the actions of peroxisome proliferator-activated receptor-alpha by bile acids.Effect of peroxisome proliferator-activated receptor-gamma ligand on inflammation of human gallbladder epithelial cells.Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury.The Role of Omega-3 Fatty Acids in Reverse Cholesterol Transport: A Review.PPARs: Nuclear Receptors Controlled by, and Controlling, Nutrient Handling through Nuclear and Cytosolic Signaling.Effects of 15d-PGJ(2) on VEGF-induced angiogenic activities and expression of VEGF receptors in endothelial cells.Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature.Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats.
P2860
Q24796541-0C7D4CB4-A931-47CE-8B54-DE8643565E16Q24801673-595B3A0A-2221-4CA9-BEB5-B280C9FBD451Q25255001-894E0DD8-7552-4626-9BA5-75089C0361FEQ28366329-413D4821-11C7-4A96-92DC-8EEA780FC32CQ28540958-29A7EFA0-453E-45F2-BCD2-19D0871573E0Q28550888-9243AB7E-D06C-4E5B-81BF-3DD545AE6D81Q28580518-D53A1AC2-3377-419E-BB26-7257F9175F42Q33778690-95ED32D3-0A19-4E0E-92EB-D0AC861F84DAQ33937214-F0574151-7EA7-49FC-A065-82A944E897CBQ33953983-659EC621-B0B0-4457-B620-F0C960B7A532Q34143718-7D43CFB3-EDD0-4FD3-96E3-6428C95DC804Q34290988-6D49AE2B-91FA-4A38-A35D-B8BB28E59ED1Q34658888-73C46227-9BC6-4338-BA3A-920CE0D4FF40Q34790065-474462BC-35D3-4C15-90F0-A41502EDB565Q34981779-1C541962-DB1F-4630-9B72-CF638E060385Q35107836-1B29A031-3856-48A2-B3CE-A0132B162608Q35210023-D3C11B96-D36F-4AF1-AFAC-FEC040C9535DQ35613290-6C4E14C2-F406-4444-A014-DC6049BF9D40Q36540016-AF9CC88A-BE9A-4395-8491-C354F7C7DDA7Q36804437-B41EBD77-AB7D-4BB8-A275-88139182ECB8Q37125986-52FBCB31-1E6A-4C29-80D8-9878DA624C44Q37165190-D5F6DDB2-DCA4-44A2-BAF2-F225CD708828Q37211800-EAE09006-81BB-4BF6-8DBF-652E1637F7B6Q37231752-0F9E1C62-3E31-4C96-BD83-C18019748494Q37278866-129C9E61-82B7-46EA-9176-DE54408D2DAAQ38128537-5D507320-0A70-4930-8300-E78F94E5A4BFQ38320967-10E20DBD-AB1D-4886-A1C4-A9DC0A255FB7Q38510084-F57256E0-CD3D-4B6B-93B0-CB32D681B08DQ39533142-D7D21378-A80F-4BA9-906B-4F297D160F32Q40237842-9581A1D2-C040-490D-AB9F-AB31D116521EQ40341163-C6F525C5-893E-4A81-AC85-A8590E336645Q40373462-6202FF7C-961F-4E90-84DB-EBCDF518CC17Q40773905-922B6DD6-3682-48A5-8E3E-2EBACBD3771DQ40820822-9615F88E-526A-458F-BC16-50E37905D747Q41886732-7937C6AE-78B2-4890-94CB-3F8926F07F09Q41990404-7658CFF7-B31A-42C8-8694-DD830C870F5FQ42093464-A00904F0-4206-4665-8882-F95DDBFB0865Q42530171-15E3777B-CAAE-4A3F-9ADC-680898C41AD8Q43796622-0F777A34-45C5-4C46-A06E-50BCC8FE7E8EQ44925431-9DAA261B-19CA-4CB2-8290-228CB278FC13
P2860
Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions.
@ast
Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions.
@en
type
label
Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions.
@ast
Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions.
@en
prefLabel
Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions.
@ast
Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions.
@en
P1476
Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions.
@en
P2093
P304
P356
10.1016/S0958-1669(99)00030-0
P577
1999-12-01T00:00:00Z